Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria.

Clinical genetics - 1 Jan 2014

Singer C F, Muhr D, Rappaport C, Tea M-K, Gschwantler-Kaulich D, Fink-Retter A, Pfeiler G, Berger A, Sun P, Narod S A

Abstract excerpt

The objective of this study was to describe the experience of genetic testing in Austrian women with a BRCA1 or BRCA2 mutation in terms of preventive measures taken and incident cancers diagnosed. We collected clinical information on 246 Austrian women with a BRCA1 or BRCA2 mutation tested between 1995 and 2012 and followed 182 of them for an average of 6.5 years. Of the 90 women who were cancer-free at baseline,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Austria
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Mastectomy

Share to Mutation Rate

Share to Ovariectomy

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 23772696
DOI: 10.1111/cge.12216

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria.PMID 23772696Read ↗

Prophylactic mastectomies in patients with breast cancer and known germline pathogenetic variants: an Austrian registrySemantic proximity Read ↗

AGO Austria recommendations for genetic testing of patients with ovarian cancer.Semantic proximity Read ↗

Post-mastectomy surveillance of BRCA1/BRCA2 mutation carriers: Outcomes from a specialized clinic for high-risk breast cancer patients.Semantic proximity Read ↗

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.Semantic proximity Read ↗

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.Semantic proximity Read ↗

Prophylactic mastectomies and bilateral salpingo-oophorectomies in patients with breast cancer and BRCA mutation: an Austrian registrySemantic proximity Read ↗

The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.Semantic proximity Read ↗

Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study.Semantic proximity Read ↗

High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan.Semantic proximity Read ↗

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients.Semantic proximity Read ↗

Management of women at increased risk for hereditary breast cancer.Semantic proximity Read ↗

Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.